Average Cost of Domestic Development Was 48.4 Billion Yen per Drug from 2000-2008: OPIR

July 29, 2013
The Japan Pharmaceutical Manufacturers Association’s Office of Pharmaceutical Industry Research (OPIR) published a research paper on July 25 that presents the results of a questionnaire survey on new drug development costs for which non-clinical and clinical trials were conducted by...read more